New candidate tumor-suppressor gene KLF6 and its splice variant KLF6 SV2 counterbalancing expression in primary hepatocarcinoma

Hepato-Gastroenterology

Volumn 59, Issue 114, 2012, Pages 473-476

  Zhou, Zhenzhen ^a   Tian, De'an ^a   Xia, Limin ^a   Yan, Wei ^a   Luo, Min ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Hepatocarcinoma; KLF6; KLF6 SV2; Tumor inhibition; Tumor suppressor gene

Indexed keywords

KRUPPEL LIKE FACTOR 6; MESSENGER RNA;

ADULT; ARTICLE; CANCER SIZE; CANCER TISSUE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HEP G2 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEINS; VENOUS THROMBOSIS;

EID: 84860579356     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11283     Document Type: Article

References (20)

1. Parkin DM, Bray F, Ferlay J, et al.: Gloabal cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
2. Sherman M: Hepatocellular carcinoma: epidemiology, risk factors, and screening Semin Liver Dis 2005; 25:143-154.
3. Zhang X, Xu HJ, Murakami Y, et al.: Deletions of chromosome 13q, mutations in Retinoblastoma, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res 1994; 54:4177-4182. (Pubitemid 24258127)
4. Vautier G, Bomford AB, Portmann BC, et al.: 53 mutations in British patients with hepatocellular carcinoma: clustering in genetic hemochromatosisl. Gatroenterology 1999; 117:154-1601.
5. Leon M, Kew MC: Analysis of ras gene mutations in hepatocellular carcinoma in southern African blacks. Anticancer Res 1995; 15:859-8611.
6. Ratziu V, Lalazar A, Wong L, et al.: Zf9, a Kruppel21ike transcription factor up-regulated in vivo during early hepatic fibrosis.Proc Nat Acad Sci U S A 1998; 95:9500-9505. (Pubitemid 28506260)
7. Kojima S, Hayashi S, Shimokado K, et al.: Transcriptional activation of urokinase by the Kruppel- like factor ZP9/COPEB activates latent TGF-beta 1 in vascular endothelial cells. Blood 2000; 95:1309-1316. (Pubitemid 30099840)
8. Narla G, Heath KE, Reeves HL, et al.: KLF6, a candidate tumor suppressor gene mutates in prostate cancer. Science 2001; 294:2563-2566. (Pubitemid 34027299)
9. Wikman H, Kettunen E, Seppanen J K, et al.: Identification of diferennally expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 2002; 21:5804-5813. (Pubitemid 35333015)
10. Reeves HL, Narla G, Ogunbiyi O, et al.: Kruppel- like factor 6 (KLF6) is a tumor suppressor gene frequently inactivated in colorectal cancer. Gastroenterology 2004; 126:1090-1103. (Pubitemid 38451180)
11. Jeng YM, Hsu HC: KLF6, a putative tumor suppressor gene is mutated in astrocytic gliomas. Int J cancer 2003; 105:625-629.
12. Ito G, Uchiyama M, Kondo M, et al.: KLF6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells. Cancer Res 2004; 64:3838-3843. (Pubitemid 38697293)
13. Kremer-Tal S, Reeves HL, et al.: Frequent inactivation of the tumor suppress or kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology 2004; 40:1047-1052. (Pubitemid 39425559)
14. Shaoping W, Xiaoping C, Fazu Q: Detection of KLF6 mRNA mutation in PHC Tissues. Chinese Journal of Surgery 2004; 42:1258-1261.
15. Sirach E, Bureau C, Péron JM, et al.: KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis. Cell Death and Differentiation 2007; 14:1202-1210. (Pubitemid 46785109)
16. Nicolas PK, Jose LB, Graciela M, et al.: A novel human zinc finger protein that interacts with the core promoter element of a TATA box-less gene. The Journal of Biological Chemistry 1997; 272(14):9573-9580.
17. Narla G, DiFeo A, et al.: A Germline DNA Polymorphism Enhances Alternative Splicing of the KLF6 Tumor Suppressor Gene and Is Associated with Increased Prostate Cancer Risk. Cancer Res 2005; 65:(4)1213-1222.
18. Narla G, DiFeo A, et al.: Targeted Inhibition of the KLF6 Splice Variant, KLF6 SV1, Suppresses Prostate Cancer Cell Growth and Spread. Cancer Res 2005; 65:5761-5768. (Pubitemid 40911179)
19. Yong GC, Chang JK, Cho HP, et al.: Genetic alteration of the KLF6 gene in gastric cancer. Oncogene 2005; 24:4588-4590.
20. McKie AB, Douglas DA, Olijslagers S, et al.: Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer. Oncogene 2005; 24(13):2166-74. (Pubitemid 40516583)